NCT00980005 - Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children | Biotech Hunter

Enrollment

2,116

Participants

Timeline

Start Date

October 13, 2009

Primary Completion Date

March 2, 2010

Study Completion Date

June 17, 2010

Conditions

Influenza

Interventions

BIOLOGICAL

GSK investigational vaccine GSK1557482A

One intramuscular injection for primed subjects, two intramuscular injections for unprimed subjects

BIOLOGICAL

Fluzone®

One intramuscular injection for primed subjects, two intramuscular injections for unprimed subjects

Trial Locations (28)

13045

GSK Investigational Site, Cortland

13210

GSK Investigational Site, Syracuse

16148

GSK Investigational Site, Hermitage

16505

GSK Investigational Site, Erie

22015

GSK Investigational Site, Burke

27518

GSK Investigational Site, Cary

27609

GSK Investigational Site, Raleigh

29406

GSK Investigational Site, Charleston

30062

GSK Investigational Site, Marietta

30189

GSK Investigational Site, Woodstock

35205

GSK Investigational Site, Birmingham

44515

GSK Investigational Site, Austintown

49127

GSK Investigational Site, Stevensville

60115

GSK Investigational Site, DeKalb

63141

GSK Investigational Site, St Louis

67114

GSK Investigational Site, Newton

67207

GSK Investigational Site, Wichita

72015

GSK Investigational Site, Benton

77055

GSK Investigational Site, Houston

78705

GSK Investigational Site, Austin

84057

GSK Investigational Site, Orem

84604

GSK Investigational Site, Provo

89015

GSK Investigational Site, Henderson

90723

GSK Investigational Site, Paramount

91790

GSK Investigational Site, West Covina

92647

GSK Investigational Site, Huntington Beach

97322

GSK Investigational Site, Albany

01801

GSK Investigational Site, Woburn